Aligning expert commentary with a key regulatory milestone to inform early media narratives
Our client is a leading non-profit association in a specific medical/research field and was anticipating a high-impact FDA decision that stood to influence both public perception and scientific dialogue. However, the regulatory outcome took an unexpected turn, creating a narrow window to reframe the moment with a strategic pivot. With our speed and flexibility, Russo Partners’ role kept the client’s perspective front and center during a time of heightened visibility.
The objective was to position the client as a trusted voice at a time when expert commentary could influence the broader landscape from the FDA’s decision. With the regulatory outcome prompting wide attention and potential confusion, a clear and credible point of view became essential for shaping how the field responded. This ideally would be in the form of an op-ed in The Wall Street Journal.
Critical pre-work
The team identified formats and outlets that would have the most impact both within the client’s field of expertise and the public before landing on The Wall Street Journal. We continuously screened for upcoming regulatory and scientific milestones within the field to be on standby.
Timing
The team synchronized publication with the day of the FDA decision to ensure the client’s voice entered the conversation at its most visible point.
Change in plans
When the FDA took an unforeseen course of action, the team swiftly adjusted, drafting a new statement overnight to reshape the narrative and mobilized to get the message out.
Message authority
The final messaging helped guide how early reporting contextualized the FDA’s decision and broader field implications.
Measurable Impact
The campaign delivered tangible results:
- Placement in The Wall Street Journal: The client’s perspective was featured in a nationally respected publication, ensuring visibility among key audiences during a pivotal regulatory moment.
- Further media syndication: The rapid response strategy resulted in coverage across national and industry-specific outlets, gaining a significant FSOV (Share of Voice) in the total conversation.
- Thought leadership established: By strategically timing and placing the client’s message, Russo Partners positioned the client as a leading voice in the field during this critical regulatory moment, reinforcing their authority on the subject.
- Increased philanthropic engagement: The campaign contributed to a notable uptick in donor interest, resulting in $2 million in new donations following the media exposure.
By applying strategic foresight and media agility, Russo Partners transformed a disruptive regulatory moment into an opportunity for the client to assert public authority. The use of timely, credible commentary ensured the client’s perspective not only entered the conversation early but also helped shape its direction across media and stakeholder communities.
